Specialized bone reconstruction techniques known as Bioactive Bone Grafts are frequently used in a variety of bone reconstruction procedures. The typical components of bone grafts include an osteoconductive matrix, which provides a framework for the development of new bone fibers, osteoinductive proteins, which support the mutagenesis of identical bone cells, and osteogenic cells, which, in the right conditions, can generate new bone. The main reason bone grafts are used is to promote bone healing after fractures and other injuries.
Bioactive bone grafts play a significant role in the process of bone regrowth by supplying nutrients, oxygen, lymph, and other vital growth factors for bone growth. They are created with optimized porosity that promotes rapid vascularization. The bioactive bone grafts are designed to be simple to handle and store. Bioactive bone grafts can be formed into a variety of shapes to accommodate different surgical and operative requirements. Furthermore, the bioactive bone grafts’ prefilled syringes enable the quick and effective application.
Bioactive Bone Grafts Market: Drivers and RestraintsDue to their advantages over other allograft techniques, bioactive bone grafts are among the most popular choices of bone graft in various bone reconstruction surgeries, such as maxillofacial surgical procedures.
The market for bioactive bone grafts is expected to grow as more orthopedic procedures and musculoskeletal disorders call for the use of these materials. For instance, the American Academy of Orthopedic Surgeons (AAOS) estimates that every year in the United States alone, close to 2.8 million musculoskeletal surgical procedures are carried out. Additionally, bone grafts and bioactive bone grafts are used in approximately 2.1 million orthopedic surgeries annually in the United States.
The market for bioactive bone grafts is therefore expected to grow as a result of increasing bioactive material demand from orthopedic disorders and growing bioactive bone graft adoption. Additionally, major market players are launching new products in the bioactive bone grafts segment, luring more consumers and fueling the market’s expansion. As an illustration, Baxter announced in September 2018 that its ALTAPORE Bioactive Bone Grafts had been approved by the US Food and Drug Administration.
Bioactive Bone Grafts Market: OverviewDue to the rising demand for cutting-edge bone growth solutions as well as ongoing research and product innovation in orthopedic care, the market for bioactive bone grafts is expanding significantly on a global scale.
Major manufacturers like Baxter and DePuy Synthes Companies are present in the bioactive bone grafts market, but it is still highly fragmented. The market for bioactive bone grafts is anticipated to expand due to the advanced enhancement properties of these materials, such as improved porosity, increased cellular activity, and a larger volume of newly formed bone. Bioactive bone grafts are used during surgery to provide an additional osteoconductive scaffold for new bone growth as well as enhanced bioactivity for quick bone growth with calcium phosphate deposition.
The main market participants for bioactive bone growth are concentrated on offering cutting-edge bioactive bone growth products and enhancing clinical results. The market for bioactive bone grafts is expected to be driven primarily by the growing geriatric population with arthritis and the rise in accidents.
Bioactive Bone Grafts Market: Region-Wise OverviewThe following geographical divisions make up the global market for bioactive bone grafts: North America, Latin America, Western Europe, Eastern Europe, and Asia-Pacific excluding the Middle East and Africa, China, and Japan. A growing geriatric population in the region has made North America the dominant regional market for bioactive bone grafts. Due to the concentration of bioactive bone graft manufacturers in the country and rising investments in cutting-edge medical technologies, the U.S. dominates the market in North America.
Due to the widespread availability of bioactive bone grafts and the region’s growing technological advancement in orthopedic technologies, Europe is expected to be the second-dominating regional market for these products. Due to rising demand for standard orthopedic care, an increase in orthopedic injuries, and an increase in geriatrics in nations like China and India, APAC is a rapidly expanding regional market for bioactive bone grafts. Due to steadily rising healthcare costs, growth in Latin America, the Middle East, and Africa is increasing gradually.
Bioactive Bone Grafts Market: Key ParticipantsExamples of some of the key participants in the Bioactive Bone Grafts market are Baxter International, Inc., DePuy Synthes Companies, Medtronic plc., NuVasive, Inc., Orthofix Holdings, Inc., Stryker Corporation, Wright Medical Technology, Inc., Zimmer Biomet Holdings, Inc., and Bioventus. Among others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, applications, and industries.
Bioactive Bone Grafts Market: segmentation based on product type, the Bioactive Bone Grafts market is segmented into:
- Putty based
Based on Application type, the Bioactive Bone Grafts market is segmented into:
- Foot and Ankle
- Joint Reconstruction
Based on End User, the Bioactive Bone Grafts market is segmented into:
- Trauma Center
- Emergency Department
For Critical Insights, Get a Sample Copy